Acute Coronary Syndrome
Cough and Cold
Vitamins and Supplements
Exciting New Advances in Lipid Management: Report from the Annual ACC, ADA and AGS Meetings
Sunday, August 1, 2004
Tweet your thoughts about this article @Pharmacy_Times
Join the conversation on the Pharmacy Times Facebook page
Sign up for our eNews to get the latest news and updates delivered to your inbox
Pradaxa Now Approved for Hip Replacement Patients
The FDA has approved Boehringer Ingelheim’s oral direct thrombin inhibitor dabigatran etexilate mesylate (Pradaxa) for the prophylaxis of deep vein thrombosis and pulmonary embolism in patients who have had hip replacement surgery.
Pharmacies' Certification Deadline Extended for Clozapine REMS Program
As a result of implementation difficulties, the FDA announced that it will extend the pharmacy certification deadline for the clozapine risk evaluation and mitigation strategy program.
Pharmacies Earn Top Scores in Customer Service
Pharmacies are rated as some of the best places to receive top-notch customer service in America.
Acid Reflux and EoE: A Complex Relationship
Often caused by acid reflux, eosinophilic esophagitis is an emerging inflammatory disease that is generally unresponsive to proton pump inhibitor therapy.
MORE ARTICLES >>
American Journal of Managed Care
Specialty Pharmacy Times
Advertise With Us
Terms & Conditions
666 Plainsboro Road
Plainsboro, NJ 08536
Copyright PharmacyTimes 2006-2015
Intellisphere, LLC. All Rights Reserved.